Generated by Meeveem AI
"A specialty pharmaceutical leader in oral liquid medicines for patients with swallowing difficulties"
Rosemont Pharmaceuticals develops, manufactures and supplies oral liquid medicines for patients with swallowing difficulties. Established in 1967, the company now delivers over 130 oral liquid medicines across multiple therapeutic areas to more than 40 international markets. With manufacturing in the UK, R&D centres in the UK and Greece, and commercial operations in the US, Rosemont combines pharmaceutical expertise with global reach. Patients with dysphagia face significant medication management challenges. Rosemont advocates licensed oral liquid medications over crushing tablets, providing healthcare professionals with safe, effective alternatives that support better patient outcomes and safer medication administration.
283
Team Members
1967
Founded
Pharma
Sector
Hybrid
Work Environment
A world where every patient with swallowing difficulties has access to safe, effective liquid medications that enable them to maintain their health and independence without compromise.
To be a rapid developer, reliable manufacturer and global supplier of novel delivery, patient focused medicines.